NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球血球分離市場預測(2021年∼2028年)

Global Apheresis Market Forecast 2021-2028

出版商 Inkwood Research 商品編碼 1003283
出版日期 內容資訊 英文 242 Pages
商品交期: 2-3個工作天內
價格
全球血球分離市場預測(2021年∼2028年) Global Apheresis Market Forecast 2021-2028
出版日期: 2021年05月03日內容資訊: 英文 242 Pages
簡介

全球血球分離市場,預計從2021年到2028年以8.31%的年複合成長率成長。老年人口增加,造血系疾病的盛行率,市場有利的償付政策和資金籌措,血球分離技術的進步等推動這個市場成長。

本報告提供全球血球分離市場調查,市場概要,各治療、技術、產品、用途、終端用戶、地區的市場規模的變化與預測,市場成長的推動要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 調查範圍和調查手法

  • 調查目的
  • 調查範圍
  • 調查手法
  • 假設與限制

第2章 摘要整理

  • 市場規模、估計
  • 市場概要

第3章 市場動態

  • 主要的促進因素
    • 造血系疾病的發生率
    • 血球分離技術的進步
    • 血球分離治療的有利的償付方針和資金提供
    • 老年人口增加
  • 主要的阻礙因素
    • 輸血時的血液污染的風險
    • 血球分離治療關聯的高額投資
    • 開發中國家在於熟練的專家不足

第4章 主要分析

  • 新型冠狀病毒感染疾病(COVID-19)的影響
  • 市場趨勢
  • 波特的五力分析
  • 市場機會矩陣
  • 業者情勢

第5章 血球分離市場:各治療

  • 血漿替換
  • 血小板分離術
  • 白血球分離
  • 紅血球分離
  • 其他

第6章 血球分離市場:各技術

  • 離心分離
  • 膜分離技術

第7章 血球分離市場:各產品

  • 拋棄式血球分離套件
  • 血球分離設備

第8章 血球分離市場:各用途

  • 造血系疾病
  • 神經病變
  • 自體免疫疾病
  • 腎障礙
  • 其他

第9章 血球分離市場:各終端用戶

  • 血庫、捐血中心
  • 醫院、診療所
  • 門診外科中心

第10章 地區分析

  • 北美
    • 市場規模與預測
    • 主要的成長啟用
    • 主要課題
    • 主要參與者
    • 國家分析
  • 歐洲
    • 市場規模與預測
    • 主要的成長啟用
    • 主要課題
    • 主要參與者
    • 國家分析
  • 亞太地區
    • 市場規模與預測
    • 主要的成長啟用
    • 主要課題
    • 主要參與者
    • 國家分析
  • 其他地區
    • 市場規模與預測
    • 主要的成長啟用
    • 主要課題
    • 主要參與者
    • 國家分析

第11章 競爭情形

  • 主要策略的開發
    • 合併、收購
    • 產品銷售、開發
    • 夥伴關係、契約
    • 事業擴大、發表、子公司出售
  • 企業簡介
    • ASAHI KASEI CORPORATION
    • BAXTER INTERNATIONAL INC
    • B BRAUN MELSUNGEN AG
    • CERUS CORPORATION
    • CYTOSORBENTS CORPORATION
    • FRESENIUS SE & CO KGAA (FRESENIUS KABI AG)
    • HAEMONETICS CORPORATION
    • HEMACARE CORPORATION
    • INFOMED
    • KANEKA CORPORATION
    • KAWASUMI LABORATORIES INC
    • MEDICAP CLINIC GMBH
    • MEDICA SPA
    • MILTENYI BIOTEC
    • TERUMO CORPORATION (TERUMO BCT)
目錄
Product Code: 36323

KEY FINDINGS

The global apheresis market growth is estimated to progress at a CAGR of 8.31% during the forecast period, 2021-2028. The increasing elderly population, hematologic disease prevalence, favorable reimbursement policies and funding, and technological advancements in apheresis techniques drive market growth.

MARKET INSIGHTS

Apheresis is a medical process wherein whole blood is removed from a donor or patient. The blood is separated into individual components for removing any particular component. This is done through membrane separation or centrifugation process. Blood diseases affect the total health of the body and are caused by certain genes. Some common blood diseases are von Willebrand disease (VWD), hemophilia, anemia, and blood cancer. These diseases entail blood transfusion, which is projected to increase the need for apheresis.

Plasma exchange and cytapheresis are the two most common types of apheresis used for eliminating harmful substances from the blood. Plasma exchange is utilized for treating disorders like multiple sclerosis, thrombotic thrombocytopenic purpura, myasthenia gravis, etc. Cytapheresis is a process that eliminates the excess number of blood cells. It is used to treat polycythemia, thrombocythemia, and leukemia. The growing incidence of hematologic diseases is thus evaluated to promote market growth.

REGIONAL INSIGHTS

The global apheresis market growth assessment includes the analysis of Asia-Pacific, Europe, North America, and Rest of World. North America is set to be the dominating region in the global market. The growing number of neurology apheresis procedures and the increasing number of plasma exchange procedures are contributing to the market prospects of the region.

COMPETITIVE INSIGHTS

Some of the eminent companies in the market are Cytosorbents Corporation, Asahi Kasei Corporation, Baxter International Inc, B Braun Melsungen AG, Cerus Corporation, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. PREVAILING INCIDENCE OF HEMATOLOGIC DISEASES
    • 3.1.2. ADVANCEMENT IN TECHNOLOGIES OF APHERESIS TECHNIQUE
    • 3.1.3. FAVORABLE REIMBURSEMENT POLICIES AND FUNDING FOR APHERESIS PROCEDURES
    • 3.1.4. GROWING GERIATRIC POPULATION
  • 3.2. KEY RESTRAINTS
    • 3.2.1. RISK OF BLOOD CONTAMINATION WHILE CONDUCTING TRANSFUSIONS
    • 3.2.2. HIGH COST OF INVESTMENT ASSOCIATED WITH APHERESIS PROCEDURES
    • 3.2.3. LACK OF SKILLED PROFESSIONALS IN DEVELOPING AND UNDERDEVELOPED COUNTRIES

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON APHERESIS MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRY
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY PROCEDURE

  • 5.1. PLASMAPHERESIS
  • 5.2. PLATELETPHERESIS
  • 5.3. LEUKAPHERESIS
  • 5.4. ERYTHROCYTAPHERESIS
  • 5.5. OTHER APHERESIS PROCEDURES

6. MARKET BY TECHNOLOGY

  • 6.1. CENTRIFUGATION
  • 6.2. MEMBRANE SEPARATION

7. MARKET BY PRODUCT

  • 7.1. DISPOSABLE APHERESIS KITS
  • 7.2. APHERESIS MACHINE

8. MARKET BY APPLICATION

  • 8.1. HEMATOLOGICAL DISORDERS
  • 8.2. NEUROLOGICAL DISORDERS
  • 8.3. AUTOIMMUNE DISORDERS
  • 8.4. RENAL DISORDERS
  • 8.5. OTHER APPLICATIONS

9. MARKET BY END-USER

  • 9.1. BLOOD BANKS/ BLOOD DONATION CENTERS
  • 9.2. HOSPITALS & CLINICS
  • 9.3. AMBULATORY SURGICAL CENTERS

10. GEOGRAPHICAL ANALYSIS

  • 10.1. NORTH AMERICA
    • 10.1.1. MARKET SIZE & ESTIMATES
    • 10.1.2. KEY GROWTH ENABLERS
    • 10.1.3. KEY CHALLENGES
    • 10.1.4. KEY PLAYERS
    • 10.1.5. COUNTRY ANALYSIS
      • 10.1.5.1. UNITED STATES
      • 10.1.5.2. CANADA
  • 10.2. EUROPE
    • 10.2.1. MARKET SIZE & ESTIMATES
    • 10.2.2. KEY GROWTH ENABLERS
    • 10.2.3. KEY CHALLENGES
    • 10.2.4. KEY PLAYERS
    • 10.2.5. COUNTRY ANALYSIS
      • 10.2.5.1. GERMANY
      • 10.2.5.2. FRANCE
      • 10.2.5.3. UNITED KINGDOM
      • 10.2.5.4. ITALY
      • 10.2.5.5. RUSSIA
      • 10.2.5.6. BELGIUM
      • 10.2.5.7. POLAND
      • 10.2.5.8. REST OF EUROPE
  • 10.3. ASIA-PACIFIC
    • 10.3.1. MARKET SIZE & ESTIMATES
    • 10.3.2. KEY GROWTH ENABLERS
    • 10.3.3. KEY CHALLENGES
    • 10.3.4. KEY PLAYERS
    • 10.3.5. COUNTRY ANALYSIS
      • 10.3.5.1. CHINA
      • 10.3.5.2. JAPAN
      • 10.3.5.3. INDIA
      • 10.3.5.4. AUSTRALIA & NEW ZEALAND
      • 10.3.5.5. SOUTH KOREA
      • 10.3.5.6. INDONESIA
      • 10.3.5.7. THAILAND
      • 10.3.5.8. VIETNAM
      • 10.3.5.9. REST OF ASIA-PACIFIC
  • 10.4. REST OF WORLD
    • 10.4.1. MARKET SIZE & ESTIMATES
    • 10.4.2. KEY GROWTH ENABLERS
    • 10.4.3. KEY CHALLENGE
    • 10.4.4. KEY PLAYERS
    • 10.4.5. REGIONAL ANALYSIS
      • 10.4.5.1. LATIN AMERICA
      • 10.4.5.2. MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. KEY STRATEGIC DEVELOPMENTS
    • 11.1.1. MERGERS & ACQUISITIONS
    • 11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 11.1.3. PARTNERSHIPS & AGREEMENTS
    • 11.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
  • 11.2. COMPANY PROFILES
    • 11.2.1. ASAHI KASEI CORPORATION
    • 11.2.2. BAXTER INTERNATIONAL INC
    • 11.2.3. B BRAUN MELSUNGEN AG
    • 11.2.4. CERUS CORPORATION
    • 11.2.5. CYTOSORBENTS CORPORATION
    • 11.2.6. FRESENIUS SE & CO KGAA (FRESENIUS KABI AG)
    • 11.2.7. HAEMONETICS CORPORATION
    • 11.2.8. HEMACARE CORPORATION
    • 11.2.9. INFOMED
    • 11.2.10. KANEKA CORPORATION
    • 11.2.11. KAWASUMI LABORATORIES INC
    • 11.2.12. MEDICAP CLINIC GMBH
    • 11.2.13. MEDICA SPA
    • 11.2.14. MILTENYI BIOTEC
    • 11.2.15. TERUMO CORPORATION (TERUMO BCT)

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - APHERESIS
  • TABLE 2: GLOBAL APHERESIS MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: GLOBAL APHERESIS MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL PLASMAPHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: GLOBAL PLASMAPHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL PLATELETPHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: GLOBAL PLATELETPHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL LEUKAPHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: GLOBAL LEUKAPHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL ERYTHROCYTAPHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: GLOBAL ERYTHROCYTAPHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL OTHER APHERESIS PROCEDURES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: GLOBAL OTHER APHERESIS PROCEDURES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL APHERESIS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: GLOBAL APHERESIS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL CENTRIFUGATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 17: GLOBAL CENTRIFUGATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL MEMBRANE SEPARATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 19: GLOBAL MEMBRANE SEPARATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL APHERESIS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 21: GLOBAL APHERESIS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL DISPOSABLE APHERESIS KITS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 23: GLOBAL DISPOSABLE APHERESIS KITS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL APHERESIS MACHINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 25: GLOBAL APHERESIS MACHINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL APHERESIS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 27: GLOBAL APHERESIS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL HEMATOLOGICAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 29: GLOBAL HEMATOLOGICAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 31: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL AUTOIMMUNE DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 33: GLOBAL AUTOIMMUNE DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL RENAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 35: GLOBAL RENAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 37: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL APHERESIS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 39: GLOBAL APHERESIS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL BLOOD BANKS/ BLOOD DONATION CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 41: GLOBAL BLOOD BANKS/ BLOOD DONATION CENTERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 43: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 45: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 46: GLOBAL APHERESIS MARKET, BY REGION, HISTORIC YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 47: GLOBAL APHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 48: NORTH AMERICA APHERESIS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 49: NORTH AMERICA APHERESIS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 50: LEADING PLAYERS OPERATING IN NORTH AMERICA APHERESIS MARKET
  • TABLE 51: EUROPE APHERESIS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 52: EUROPE APHERESIS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 53: LEADING PLAYERS OPERATING IN EUROPE APHERESIS MARKET
  • TABLE 54: ASIA-PACIFIC APHERESIS MARKET, BY COUNTRY, HISTORIC YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 55: ASIA-PACIFIC APHERESIS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 56: LEADING PLAYERS OPERATING IN ASIA-PACIFIC APHERESIS MARKET
  • TABLE 57: REST OF WORLD APHERESIS MARKET, BY REGION, HISTORIC YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 58: REST OF WORLD APHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 59: LEADING PLAYERS OPERATING IN REST OF WORLD APHERESIS MARKET
  • TABLE 60: LIST OF MERGERS & ACQUISITIONS
  • TABLE 61: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 62: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 63: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: GLOBAL APHERESIS MARKET, BY PROCEDURE, IN 2020
  • FIGURE 6: GLOBAL APHERESIS MARKET, BY PLASMAPHERESIS, 2021-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL APHERESIS MARKET, BY PLATELETPHERESIS, 2021-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL APHERESIS MARKET, BY LEUKAPHERESIS, 2021-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL APHERESIS MARKET, BY ERYTHROCYTAPHERESIS, 2021-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL APHERESIS MARKET, BY OTHER APHERESIS PROCEDURES, 2021-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL APHERESIS MARKET, BY TECHNOLOGY, IN 2020
  • FIGURE 12: GLOBAL APHERESIS MARKET, BY CENTRIFUGATION, 2021-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL APHERESIS MARKET, BY MEMBRANE SEPARATION, 2021-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL APHERESIS MARKET, BY PRODUCT, IN 2020
  • FIGURE 15: GLOBAL APHERESIS MARKET, BY DISPOSABLE APHERESIS KITS, 2021-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL APHERESIS MARKET, BY APHERESIS MACHINE, 2021-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL APHERESIS MARKET, BY APPLICATION, IN 2020
  • FIGURE 18: GLOBAL APHERESIS MARKET, BY HEMATOLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 19: PREVALENCE OF BLEEDING DISORDER GLOBALLY, IN 2019
  • FIGURE 20: GLOBAL APHERESIS MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL APHERESIS MARKET, BY AUTOIMMUNE DISORDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL APHERESIS MARKET, BY RENAL DISORDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL APHERESIS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL APHERESIS MARKET, BY END-USER, IN 2020
  • FIGURE 25: GLOBAL APHERESIS MARKET, BY BLOOD BANKS/ BLOOD DONATION CENTERS, 2021-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL APHERESIS MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL APHERESIS MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)
  • FIGURE 28: NORTH AMERICA APHERESIS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 29: UNITED STATES APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 30: CANADA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 31: EUROPE APHERESIS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 32: GERMANY APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 33: FRANCE APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 34: UNITED KINGDOM APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 35: ITALY APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 36: RUSSIA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 37: BELGIUM APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 38: POLAND APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 39: REST OF EUROPE APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 40: ASIA-PACIFIC APHERESIS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 41: CHINA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 42: JAPAN APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 43: INDIA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 44: AUSTRALIA & NEW ZEALAND APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 45: SOUTH KOREA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 46: INDONESIA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 47: THAILAND APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 48: VIETNAM APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 49: REST OF ASIA-PACIFIC APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 50: REST OF WORLD APHERESIS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 51: LATIN AMERICA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 52: MIDDLE EAST & AFRICA APHERESIS MARKET, 2021-2028 (IN $ MILLION)